Safety and Pharmacokinetics of Intravenous and Oral Posaconazole in Immunocompromised Children (MK-5592-097)

NCT02452034 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

118

Enrollment

INDUSTRY

Sponsor class

Conditions

Neutropenia

Interventions

DRUG: Posaconazole IV solution
DRUG: Posaconazole powder for oral suspension

Sponsor

Merck Sharp & Dohme LLC